PRODUCTS

GW1516 5mg/ml 30ml
September 19, 2017
T3 – 100MCG/ml x 60ML
September 19, 2017

Ostarine – (MK-2866) 25 mg/ml X 60ML

$119.99

Ostarine ((2R)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide) (also known as MK-2866) is an investigational selective androgen receptor modulator (SARM) from GTx Inx, for treatment of conditions such as muscle wasting and osteoporosis, formerly under development by Merck & Company.

Description

Ostarine ((2R)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide) (also known as MK-2866) is an investigational selective androgen receptor modulator (SARM) from GTx Inx, for treatment of conditions such as muscle wasting and osteoporosis, formerly under development by Merck & Company.[1] Structure According to a recent paper authored by GTx, “Readers are cautioned to note that the name Ostarine is often mistakenly linked to the chemical structure of [S-4], which is also known as andarine. The chemical structure of Ostarine has not been publicly disclosed.”[2] While GTx has not formally disclosed the structure of Ostarine, the chemical composition of Ostarine is revealed in patent databases such the WIPO[3] and discussed by Zhang et al., 2009 in the primary literature.[4] Various SARM chemotypes exist (aryl propionamides, quinolines, quinolinones, bicyclic hydantoins), though aryl propionamides such as Ostarine, Andarine/S-4, and S-23 represent some of the most advanced putative therapeutics under investigation.[5] In terms of atom connectivity, Ostarine differs from Andarine by cyano substitutions on the phenyl rings as it replaces both the nitro and acetamido moieties. PRODUCT IS NOT FOR HUMAN OR ANIMAL USE. PRODUCT IS FOR RESEARCH PURPOSE ONLY.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Ostarine – (MK-2866) 25 mg/ml X 60ML”

Your email address will not be published. Required fields are marked *